NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
13 hedge funds and large institutions have $47.9M invested in NKGen Biotech, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
13
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$17.2M | |
| 2 | +$3.91M | |
| 3 | +$770K | |
| 4 |
CS
Clear Street
New York
|
+$608K |
Top Sellers
| 1 | -$6.63M | |
| 2 | -$6.41M | |
| 3 | -$5.68M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$3.27M |
| 5 |
KL
KIM LLC
Wichita,
Kansas
|
-$3.1M |